ACADIA Pharmaceuticals, Inc. (ACAD)

26.14 -0.64 (-2.39%) USD  |  NASDAQ  |  Jan 12, 11:48
More

ACADIA Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade